EVAXION BIOTECH A/S (EVAX)

US29970R2040 - ADR

4.18  +0.06 (+1.46%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
25.26M25.83M16.57M10.86M5.63M
Research and Development
17.04M19.61M11.61M8.65M3.67M
Selling, General, and Administrative Expenses
8.07M6.18M5.65M2.63M1.88M
Operating Income
-25.26M-25.83M-16.57M-10.86M-5.63M
Interest Income/Expense
1.32M1.12M-10.00K-1.16M-640.00K
Income Before Taxes
-23.94M-24.71M-16.58M-12.02M-6.27M
Income Tax
-770.00K-180.00K-1.56M-830.00K-740.00K
Net Income
-23.17M-24.53M-15.02M-11.20M-5.54M
EBITDA
-24.69M-25.49M-16.46M-10.78M-5.56M
 
Per Share Data
EPS Diluted Total Ops
-5.63-7.24-4.54-3.33-1.67
Non GAAP EPS
-3.59-1.25N/AN/AN/A
 
Statistics

All data in USD

Charts